PARNAX LAB LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 09/11/2023 ,inter alia, to consider and approve Standalone and Consolidated Un-audited IND- AS Compliant Financial Results along with Limited Review Report for the quarter (Q2) and half year ended 30th September, 2023, pursuant to Regulation 33 of Listing Obligation and Disclosure Requirement, 2015. 2. Any other business with the permission of the Chair. Kindly note that the approved results will be sent to you after the conclusion of the Board meeting. Kindly acknowledge the receipt of the same and Oblige